Yelin Lapidot Holdings Management »

Chemomab Therapeutics shares owned by Yelin Lapidot Holdings Management

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Yelin Lapidot Holdings Management from 13F filings

Historical chart of Yelin Lapidot Holdings Management investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Yelin Lapidot Holdings Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Yelin Lapidot Holdings Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 810k 1.57

More positions owned by Yelin Lapidot Holdings Management

Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Financial (XLF)
Zim Integrated Shipping Serv SHS (ZIM)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Meta Platforms Cl A (META)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Etf Ser Solutions Us Glb Jets (JETS)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Mediwound Shs New (MDWD)
Global E Online SHS (GLBE)
International Flavors & Fragrances (IFF)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Yelin Lapidot Holdings Management

Top funds holding Chemomab Therapeutics

OrbiMed Advisors
Yelin Lapidot Holdings Management
Ikarian Capital
Kestra Private Wealth Services
Rhumbline Advisers
Two Sigma Investments
Two Sigma Advisers
Hrt Financial
Morgan Stanley
Jpmorgan Chase & Co
Moser Wealth Advisors
Qube Research & Technologies

View all funds holding Chemomab Therapeutics